Cargando…

Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity

AIMS/HYPOTHESIS: The incidence of type 1 diabetes is increasing more rapidly than can be explained by genetic drift. Viruses may play an important role in the disease, as they seem to activate the 2′-5′-linked oligoadenylate (2′-5′A) pathway of the innate antiviral immune system. Our aim was to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Kristina, Haupt-Jorgensen, Martin, Krogvold, Lars, Kaur, Simranjeet, Gerling, Ivan C., Pociot, Flemming, Dahl-Jørgensen, Knut, Buschard, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245375/
https://www.ncbi.nlm.nih.gov/pubmed/33973017
http://dx.doi.org/10.1007/s00125-021-05469-5
_version_ 1783716102488981504
author Pedersen, Kristina
Haupt-Jorgensen, Martin
Krogvold, Lars
Kaur, Simranjeet
Gerling, Ivan C.
Pociot, Flemming
Dahl-Jørgensen, Knut
Buschard, Karsten
author_facet Pedersen, Kristina
Haupt-Jorgensen, Martin
Krogvold, Lars
Kaur, Simranjeet
Gerling, Ivan C.
Pociot, Flemming
Dahl-Jørgensen, Knut
Buschard, Karsten
author_sort Pedersen, Kristina
collection PubMed
description AIMS/HYPOTHESIS: The incidence of type 1 diabetes is increasing more rapidly than can be explained by genetic drift. Viruses may play an important role in the disease, as they seem to activate the 2′-5′-linked oligoadenylate (2′-5′A) pathway of the innate antiviral immune system. Our aim was to investigate this possibility. METHODS: Innate antiviral immune pathways were searched for type 1 diabetes-associated polymorphisms using genome-wide association study data. SNPs within ±250kb flanking regions of the transcription start site of 64 genes were examined. These pathways were also investigated for type 1 diabetes-associated RNA expression profiles using laser-dissected islets from two to five tissue sections per donor from the Diabetes Virus Detection (DiViD) study and the network of Pancreatic Organ Donors (nPOD). RESULTS: We found 27 novel SNPs in genes nominally associated with type 1 diabetes. Three of those SNPs were located upstream of the 2′-5′A pathway, namely SNP rs4767000 (p = 1.03 × 10(−9), OR 1.123), rs1034687 (p = 2.16 × 10(−7), OR 0.869) and rs739744 (p = 1.03 × 10(−9), OR 1.123). We also identified a large group of dysregulated islet genes in relation to type 1 diabetes, of which two were novel. The most aberrant genes were a group of IFN-stimulated genes. Of those, the following distinct pathways were targeted by the dysregulation (compared with the non-diabetic control group): OAS1 increased by 111% (p < 1.00 × 10(−4), 95% CI −0.43, −0.15); MX1 increased by 142% (p < 1.00 × 10(−4), 95% CI −0.52, −0.22); and ISG15 increased by 197% (p = 2.00 × 10(−4), 95% CI −0.68, −0.18). CONCLUSIONS/INTERPRETATION: We identified a genetic predisposition in the 2′-5′A pathway that potentially contributes to dysregulation of the innate antiviral immune system in type 1 diabetes. This study describes a potential role for the 2′-5′A pathway and other components of the innate antiviral immune system in beta cell autoimmunity. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-021-05469-5.
format Online
Article
Text
id pubmed-8245375
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82453752021-07-14 Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity Pedersen, Kristina Haupt-Jorgensen, Martin Krogvold, Lars Kaur, Simranjeet Gerling, Ivan C. Pociot, Flemming Dahl-Jørgensen, Knut Buschard, Karsten Diabetologia Article AIMS/HYPOTHESIS: The incidence of type 1 diabetes is increasing more rapidly than can be explained by genetic drift. Viruses may play an important role in the disease, as they seem to activate the 2′-5′-linked oligoadenylate (2′-5′A) pathway of the innate antiviral immune system. Our aim was to investigate this possibility. METHODS: Innate antiviral immune pathways were searched for type 1 diabetes-associated polymorphisms using genome-wide association study data. SNPs within ±250kb flanking regions of the transcription start site of 64 genes were examined. These pathways were also investigated for type 1 diabetes-associated RNA expression profiles using laser-dissected islets from two to five tissue sections per donor from the Diabetes Virus Detection (DiViD) study and the network of Pancreatic Organ Donors (nPOD). RESULTS: We found 27 novel SNPs in genes nominally associated with type 1 diabetes. Three of those SNPs were located upstream of the 2′-5′A pathway, namely SNP rs4767000 (p = 1.03 × 10(−9), OR 1.123), rs1034687 (p = 2.16 × 10(−7), OR 0.869) and rs739744 (p = 1.03 × 10(−9), OR 1.123). We also identified a large group of dysregulated islet genes in relation to type 1 diabetes, of which two were novel. The most aberrant genes were a group of IFN-stimulated genes. Of those, the following distinct pathways were targeted by the dysregulation (compared with the non-diabetic control group): OAS1 increased by 111% (p < 1.00 × 10(−4), 95% CI −0.43, −0.15); MX1 increased by 142% (p < 1.00 × 10(−4), 95% CI −0.52, −0.22); and ISG15 increased by 197% (p = 2.00 × 10(−4), 95% CI −0.68, −0.18). CONCLUSIONS/INTERPRETATION: We identified a genetic predisposition in the 2′-5′A pathway that potentially contributes to dysregulation of the innate antiviral immune system in type 1 diabetes. This study describes a potential role for the 2′-5′A pathway and other components of the innate antiviral immune system in beta cell autoimmunity. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-021-05469-5. Springer Berlin Heidelberg 2021-05-11 2021 /pmc/articles/PMC8245375/ /pubmed/33973017 http://dx.doi.org/10.1007/s00125-021-05469-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pedersen, Kristina
Haupt-Jorgensen, Martin
Krogvold, Lars
Kaur, Simranjeet
Gerling, Ivan C.
Pociot, Flemming
Dahl-Jørgensen, Knut
Buschard, Karsten
Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity
title Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity
title_full Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity
title_fullStr Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity
title_full_unstemmed Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity
title_short Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity
title_sort genetic predisposition in the 2′-5′a pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245375/
https://www.ncbi.nlm.nih.gov/pubmed/33973017
http://dx.doi.org/10.1007/s00125-021-05469-5
work_keys_str_mv AT pedersenkristina geneticpredispositioninthe25apathwayinthedevelopmentoftype1diabetespotentialcontributiontodysregulationofinnateantiviralimmunity
AT hauptjorgensenmartin geneticpredispositioninthe25apathwayinthedevelopmentoftype1diabetespotentialcontributiontodysregulationofinnateantiviralimmunity
AT krogvoldlars geneticpredispositioninthe25apathwayinthedevelopmentoftype1diabetespotentialcontributiontodysregulationofinnateantiviralimmunity
AT kaursimranjeet geneticpredispositioninthe25apathwayinthedevelopmentoftype1diabetespotentialcontributiontodysregulationofinnateantiviralimmunity
AT gerlingivanc geneticpredispositioninthe25apathwayinthedevelopmentoftype1diabetespotentialcontributiontodysregulationofinnateantiviralimmunity
AT pociotflemming geneticpredispositioninthe25apathwayinthedevelopmentoftype1diabetespotentialcontributiontodysregulationofinnateantiviralimmunity
AT dahljørgensenknut geneticpredispositioninthe25apathwayinthedevelopmentoftype1diabetespotentialcontributiontodysregulationofinnateantiviralimmunity
AT buschardkarsten geneticpredispositioninthe25apathwayinthedevelopmentoftype1diabetespotentialcontributiontodysregulationofinnateantiviralimmunity